We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UGI icon
1701
UGI
UGI
$7.33B
– –
-201,498
Closed -$8.95M
UGP icon
1702
Ultrapar
UGP
$6.54B
– –
-28,114
Closed -$304K
UHT
1703
Universal Health Realty Income Trust
UHT
$594M
– –
-13,527
Closed -$813K
UL icon
1704
Unilever
UL
$136B
– –
-3,417
Closed -$214K
UNM icon
1705
Unum
UNM
$14.3B
– –
-662,027
Closed -$31.5M
UVSP icon
1706
Univest Financial
UVSP
$1.18B
– –
-21,753
Closed -$603K
VAC icon
1707
Marriott Vacations Worldwide
VAC
$4.25B
– –
-11,344
Closed -$1.51M
VFC icon
1708
VF Corp
VFC
$5.89B
– –
-679,377
Closed -$47.4M
VICI icon
1709
VICI Properties
VICI
$29.4B
– –
-96,505
Closed -$1.77M
VNOM icon
1710
Viper Energy
VNOM
$14.7B
– –
-65,314
Closed -$1.66M
VRDN icon
1711
Viridian Therapeutics
VRDN
$2.67B
– –
-807
Closed -$85K
VRNS icon
1712
Varonis Systems
VRNS
$5B
– –
-74,022
Closed -$1.49M
VRNT
1713
DELISTED
Verint Systems
VRNT
– –
-176,633
Closed -$3.83M
VST icon
1714
Vistra
VST
$47.4B
– –
-955,329
Closed -$19.9M
VTLE
1715
DELISTED
Vital Energy
VTLE
– –
-79,882
Closed -$13.9M
VUZI icon
1716
Vuzix
VUZI
$224M
– –
-146,052
Closed -$803K
YARW
1717
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
– –
-9
Closed -$1.18M
WAB icon
1718
Wabtec
WAB
$49.3B
– –
-7,292
Closed -$594K
WAL icon
1719
Western Alliance Bancorporation
WAL
$8.87B
– –
-89,501
Closed -$5.2M
WAT icon
1720
Waters Corp
WAT
$39.9B
– –
-75,237
Closed -$14.9M
WBA
1721
DELISTED
Walgreens Boots Alliance
WBA
– –
-58,785
Closed -$3.85M
WBD icon
1722
Warner Bros
WBD
$67.1B
– –
-580,512
Closed -$12.4M
WCC
1723
WESCO International
WCC
$17.7B
– –
-95,578
Closed -$5.93M
WEC icon
1724
WEC Energy
WEC
$35.1B
– –
-23,326
Closed -$1.46M
WERN icon
1725
Werner Enterprises
WERN
$2.25B
– –
-105,406
Closed -$3.85M
67 68
69
70 71

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.